Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC
Status:
Recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether stereotactic radiosurgery combination with
Anlotinib is safe, effective in the treatment of limited brain metastases with Perilesional
edema in non-small cell lung cancer.